A Combination of Zarnestra With Velcade for Patients With Relapsed Multiple Myeloma
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00361088 |
|
Recruitment Status
:
Terminated
(Initial Principal Investigator left Moffitt)
First Posted
: August 7, 2006
Last Update Posted
: November 25, 2013
|
Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Collaborators:
Millennium Pharmaceuticals, Inc.
National Cancer Institute (NCI)
Information provided by:
H. Lee Moffitt Cancer Center and Research Institute
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | June 2007 |
| Actual Study Completion Date : | June 2007 |